4SC's partner Yakult Honsha starts clinical Phase I/II study with cancer compound resminostat in non-small-cell lung cancer (NSCLC) in Japan
. - The Phase I/II study will investigate safety and efficacy of resminostat/docetaxel combination vs. docetaxel alone…